Medication and Risk
The discussion highlights the importance of individualized treatment decisions based on a patient's risk profile for cardiovascular events. While some may benefit from lipid-lowering medications, others with low short-term risk can opt for a less aggressive approach. However, delaying treatment may lead to more significant health issues down the line, emphasizing the need for proactive management of LDL cholesterol and APOB levels.In this clip
From this podcast
The Proof with Simon Hill
Why you should test ApoB | Dan Soffer, Md
Related Questions